SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SFCC provides outsourced drug development research services

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Skywatcher who wrote (16)12/16/2005 6:48:43 PM
From: SI Bob  Read Replies (1) of 29
 
I flipped SFCC several times today without knowing anything about it other than that it was moving dramatically and rapidly back and forth.

I'm starting to do some DD on it now as a potential longer-term hold and after about half an hour of digging, did buy a small position in afterhours to keep over the weekend.

In other words, I've found more to like than dislike, in my not-very-valuable opinion.

Was this stock complacently sitting at a too-high price for a long time because of the small outstanding share count and thin trading? Or was it due for the smacking it just got?

And my wife has worked for a large CRO for just about forever and I know from talking to her that it's a very cut-throat business. This one is absolutely tiny in comparison to the one she works for (formerly public but recently taken private).

What makes this one, a comparative chimp, survivable in a market that's slowly but surely being completely controlled by just a few 800-lb gorillas?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext